Search research articles
Contact Us
Filters
Showing results (11-20 of 218) with videos related to
Page
of 22
Sort By:
Cardiovascular Research
|
August 22, 2013
Antioxidant effects of phosphodiesterase-5 inhibitors: reply
Rui Zhang, Zhi-Cheng Jing
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|
October 29, 2008
[Acute pulmonary vasodilator testing is a critical step in the management of patients with pulmonary arterial hypertension]
Xin Jiang, Zhi-Cheng Jing
Zhonghua Yi Xue Za Zhi
|
January 6, 2005
[Treatment of acute pulmonary thromboembolism]
Zhi-cheng Jing, Ke-wu Deng
Zhonghua Nei Ke Za Zhi
|
November 9, 2013
[Combat pulmonary hypertension: long march, difficulty but successful ultimate destination]
Zhi-cheng Jing, Xi-qi Xu
Therapeutics and Clinical Risk Management
|
December 10, 2015
The limits of oral therapy in pulmonary arterial hypertension management
Qian-Qian Liu, Zhi-Cheng Jing
Zhonghua Xin Xue Guan Bing Za Zhi
|
February 14, 2008
[To standardize the screening, diagnosis and treatment of pulmonary arterial hypertension]
Da-Yi Hu, Zhi-Cheng Jing
Expert Opinion on Pharmacotherapy
|
October 5, 2020
How should a physician approach the pharmacological management of chronic thromboembolic pulmonary hypertension?
Zhuang Tian, Xin Jiang, Zhi-Cheng Jing
The European Respiratory Journal
|
June 4, 2013
Complexities of oestradiol pharmacology in pulmonary arterial hypertension
Ping Yuan, Lan Gao, Zhi-Cheng Jing
European Heart Journal
|
December 22, 2019
The Key Laboratory of Pulmonary Vascular Medicine, Chinese Academy of Medical Sciences (KLPVM-CAMS)
Xin Jiang, Xi-Qi Xu, Zhi-Cheng Jing
Frontiers in Pharmacology
|
May 28, 2020
Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
Rui Zhang, Yang-Yang He, Zhi-Cheng Jing
Page
of 22
Search research articles
Search
Showing results (11-20 of 218) with videos related to
Sort By:
Page
of 22
Cardiovascular Research
|
August 22, 2013
Antioxidant effects of phosphodiesterase-5 inhibitors: reply
Rui Zhang, Zhi-Cheng Jing
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|
October 29, 2008
[Acute pulmonary vasodilator testing is a critical step in the management of patients with pulmonary arterial hypertension]
Xin Jiang, Zhi-Cheng Jing
Zhonghua Yi Xue Za Zhi
|
January 6, 2005
[Treatment of acute pulmonary thromboembolism]
Zhi-cheng Jing, Ke-wu Deng
Zhonghua Nei Ke Za Zhi
|
November 9, 2013
[Combat pulmonary hypertension: long march, difficulty but successful ultimate destination]
Zhi-cheng Jing, Xi-qi Xu
Therapeutics and Clinical Risk Management
|
December 10, 2015
The limits of oral therapy in pulmonary arterial hypertension management
Qian-Qian Liu, Zhi-Cheng Jing
Zhonghua Xin Xue Guan Bing Za Zhi
|
February 14, 2008
[To standardize the screening, diagnosis and treatment of pulmonary arterial hypertension]
Da-Yi Hu, Zhi-Cheng Jing
Expert Opinion on Pharmacotherapy
|
October 5, 2020
How should a physician approach the pharmacological management of chronic thromboembolic pulmonary hypertension?
Zhuang Tian, Xin Jiang, Zhi-Cheng Jing
The European Respiratory Journal
|
June 4, 2013
Complexities of oestradiol pharmacology in pulmonary arterial hypertension
Ping Yuan, Lan Gao, Zhi-Cheng Jing
European Heart Journal
|
December 22, 2019
The Key Laboratory of Pulmonary Vascular Medicine, Chinese Academy of Medical Sciences (KLPVM-CAMS)
Xin Jiang, Xi-Qi Xu, Zhi-Cheng Jing
Frontiers in Pharmacology
|
May 28, 2020
Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
Rui Zhang, Yang-Yang He, Zhi-Cheng Jing
Page
of 22